首页|天麻素注射液联合倍他司汀治疗椎-基底动脉供血不足性眩晕症患者的效果

天麻素注射液联合倍他司汀治疗椎-基底动脉供血不足性眩晕症患者的效果

扫码查看
目的:探讨天麻素注射液联合倍他司汀治疗椎-基底动脉供血不足性眩晕症(VBIV)患者的效果.方法:选取 2020 年1 月至 2023 年 1 月该院收治的 82 例VBIV患者进行前瞻性研究,按照随机数字表法将其分为对照组和研究组各 41 例.对照组静脉滴注盐酸倍他司汀氯化钠注射液治疗,研究组在对照组基础上联合天麻素注射液治疗.比较两组临床疗效,症状缓解时间,治疗前后眩晕症状[眩晕障碍量表(DHI)]评分、血液流变学指标[高切全血黏度(HWBV)、血浆黏度(PV)及红细胞聚集指数(EAI)]水平,以及不良反应发生率.结果:研究组治疗总有效率为97.56%(40/41),高于对照组的75.61%(31/41),差异有统计学意义(P<0.05);研究组眩晕、恶心呕吐消失时间及平衡功能恢复时间均短于对照组,差异有统计学意义(P<0.05);治疗后,研究组DHI评分及HWBV、PV、EAI水平均低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:天麻素注射液联合倍他司汀治疗VBIV患者效果显著,可加快症状缓解,减轻眩晕症状,改善血液流变学指标,效果优于单用倍他司汀治疗.
Effects of Gastrodin injection combined with Betahistine in treatment of patients with vertebral-basilar insufficiency vertigo
Objective:To investigate effects of Gastrodin injection combined with Betahistine in treatment of patients with vertebral-basilar insufficiency vertigo(VBIV).Methods:A prospective study was conducted on 82 patients with VBIV admitted to this hospital from January 2020 to January 2023.According to the random number table method,they were divided into control group and study group,41 cases in each group.The control group was treated with intravenous drip of Betahistine hydrochloride sodium chloride injection,while the study group was treated with Gastrodin injection on the basis of that of the control group.The clinical efficacy,the symptom relief time,the vertigo symptoms[dizziness handicap inventory(DHI)]score,the hemorheology indexes[high shear whole blood viscosity(HWBV),plasma viscosity(PV)and erythrocyte aggregation index(EAI)]levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the study group was 97.56%(40/41),which was higher than 75.61%(31/41)of the control group,and the difference was statistically significant(P<0.05).The disappearance time of vertigo,nausea and vomiting and the recovery time of balance function in the study group were shorter than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the DHI score and the levels of HWBV,PV and EAI in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Gastrodin injection combined with Betahistine has a significant effect in the treatment of the VBIV patients,which can accelerate the relief of symptoms,relieve the vertigo symptoms and improve the hemorheology index levels.Moreover,it is superior to single Betahistine treatment.

Vertebral-basilar artery insufficiencyVertigoBetahistineGastrodin injectionHemorheology index

刘俊花、姜晓蕊

展开 >

郑州市第一人民医院,药学部,河南 郑州 450000

郑州市第一人民医院,神经内科,河南 郑州 450000

椎-基底动脉供血不足 眩晕症 倍他司汀 天麻素注射液 血液流变学指标

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(6)
  • 12